An interventional study of functional capacity and Fatigue and dyspnea in Heart Failure and Functional Capacity, sponsored by Necmettin Erbakan University. Active, not recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-10-07.
Sponsored by Necmettin Erbakan University · Not applicable, Interventional, and Screening
The aim of this study was to investigate the acute effects of rhythmic auditory stimulation (RAS) with metronome on functional capacity, vital signs, perceived fatigue, and dyspnea in patients diagnosed with heart failure. The participants (n=40) were divided into two groups: Group 1 (n=20) and Group 2 (n=20). Group 1 underwent the classic 6-minute walk test (6MWT), followed by a one-hour break, and then the 6MWT with rhythmic auditory stimulation. Group 2 underwent the 6MWT with rhythmic auditory stimulation, followed by a one-hour break, and then the classic 6MWT. Functional capacity was assessed using the 6MWT, vital signs using a digital blood pressure monitor and pulse oximeter, fatigue level using the modified Borg scale, and fatigue and dyspnea levels using the modified Borg scale. Assessments were performed in three stages: before the test, after the test, and during recovery.
The aim of this study was to investigate the acute effects of rhythmic auditory stimulation (RAS) with metronome on functional capacity, vital signs, perceived fatigue, and dyspnea in patients diagnosed with heart failure. The participants (n=40) were divided into two groups: Group 1 (n=20) and Group 2 (n=20). Group 1 underwent the classic 6-minute walk test (6MWT), followed by a one-hour break, and then the 6MWT with rhythmic auditory stimulation. Group 2 underwent the 6MWT with rhythmic auditory stimulation, followed by a one-hour break, and then the classic 6MWT. Functional capacity was assessed using the 6MWT, vital signs using a digital blood pressure monitor and pulse oximeter, fatigue level using the modified Borg scale, and fatigue and dyspnea levels using the modified Borg scale. Assessments were performed in three stages: before the test, after the test, and during recovery.
5,803 studies on the registry are indexed under Heart Failure; 1,222 are open to participants now.
This study's enrollment of 40 is below the median of 72 across 3,790 interventional studies indexed under Heart Failure.
Browse Heart Failure studies →Necmettin Erbakan University is the lead sponsor of 199 studies on the registry; 47 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Being 18 years of age or older,
Exclusion Criteria:
Yürümeyi veya egzersiz testini engelleyecek düzeyde ortopedik.nörolojikveya psikiyatrik hastalık tanısı bulunanlar,
Behavioral: functional capacity · Behavioral: Fatigue and dyspnea
Behavioral: functional capacity · Behavioral: Fatigue and dyspnea
First, classic 6 MWT, then 6 MWT with rhythmic auditory stimulation.
First, 6MWT with rhythmic auditory stimulation then classic 6 MWT.
Change in Functional Capacity Assessed by the 6-Minute Walk Test (6MWT)
Functional capacity will be assessed using the 6-Minute Walk Test (6MWT). The total distance walked in six minutes will be recorded in meters (m). Changes in functional capacity will be evaluated by comparing the distance walked before and one hour after the intervention. An increase in walking distance indicates an increase in functional capacity.
Time frame: Baseline (before intervention) and one hour after the intervention.
Change in Perceived Fatigue and Dyspnea Measured Using the Modified Borg Scale (0-10)
The levels of perceived fatigue and dyspnea will be assessed using the Modified Borg Scale, a subjective rating scale ranging from 0 (no symptoms) to 10 (maximal symptoms). Fatigue and dyspnea will be assessed and recorded separately. Changes in fatigue and dyspnea scores will be evaluated by comparing the scores obtained at baseline and one hour after the intervention.It shows that the level of fatigue increases as the score rises.
Time frame: Baseline (pre-intervention) and one hour after the intervention
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Necmettin Erbakan University →